Supplemental material
Drug Delivery
Volume 25, 2018 - Issue 1
Research Article
Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment
, , , , , , , , , , & 
show all
Xiujun FanLaboratory for Reproductive Health, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; Correspondence[email protected]
http://orcid.org/0000-0003-3322-1857View further author information
http://orcid.org/0000-0003-3322-1857View further author information show allRelated Research Data
Identification of glycosaminoglycan binding regions in the Plasmodium falciparum encoded placental sequestration ligand, VAR2CSA
Source:
Springer Science and Business Media LLC
Structural and Functional Insight into How thePlasmodium falciparumVAR2CSA Protein Mediates Binding to Chondroitin Sulfate A in Placental Malaria
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment
Source:
Taylor & Francis
The Chondroitin Sulfate A-binding Site of the VAR2CSA Protein Involves Multiple N-terminal Domains
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
Identification of Multiple Chondroitin Sulfate A (CSA)–Binding Domains in thevar2CSAGene Transcribed in CSA‐Binding Parasites
Source:
Oxford University Press (OUP)
Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment
Source:
Taylor & Francis
Noninvasive Monitoring of Placenta-Specific Transgene Expression by Bioluminescence Imaging
Source:
Public Library of Science (PLoS)
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform.
Source:
American Chemical Society (ACS)
Performance of Doxorubicin-Conjugated Gold Nanoparticles: Regulation of Drug Location
Source:
American Chemical Society (ACS)
Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors.
Source:
American Association for Cancer Research (AACR)
Evidence for the involvement of VAR2CSA in pregnancy-associated malaria.
Source:
Rockefeller University Press
Adherence of Plasmodium falciparum to Chondroitin Sulfate A in the Human Placenta
Source:
American Association for the Advancement of Science (AAAS)
Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications
Source:
American Society for Clinical Investigation
Gestational trophoblastic neoplasia—pathogenesis and potential therapeutic targets
Source:
Elsevier BV
Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
Source:
Elsevier BV
Formulation of Drugs in Block Copolymer Micelles: Drug Loading and Release
Source:
Bentham Science Publishers Ltd.
Pathogenesis of choriocarcinoma: clinical, genetic and stem cell perspectives
Source:
Future Medicine Ltd
Improving drug accumulation and photothermal efficacy in tumor depending on size of ICG loaded lipid-polymer nanoparticles
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs
Source:
Elsevier BV
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
Source:
American Chemical Society (ACS)
Nanoparticles containing insoluble drug for cancer therapy
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Choriocarcinoma with brain, lung and vaginal metastases successfully treated without brain radiation or intrathecal chemotherapy: A case report
Source:
Elsevier BV
Quick Synthesis of Lipid−Polymer Hybrid Nanoparticles with Low Polydispersity Using a Single-Step Sonication Method
Source:
American Chemical Society (ACS)
Nanomedicine-Challenge and Perspectives
Source:
Wiley
Gestational Trophoblastic Disease
Source:
Elsevier BV
Cancer nanotechnology: opportunities and challenges.
Source:
Springer Science and Business Media LLC
Targeting Human Cancer by a Glycosaminoglycan Binding Malaria Protein
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Gestational Trophoblastic Disease
Source:
Elsevier BV
Cancer-Specific Transgene Expression Mediated by Systemic Injection of Nanoparticles
Source:
American Association for Cancer Research (AACR)
Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia
Source:
Elsevier BV
Linking provided by
